This systematic review aimed to evaluate the prevalence, awareness, risk factors, and outcomes of preeclampsia among women in Saudi Arabia.In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we searched PubMed, Web of Science, and Cochrane databases, focusing on studies published between 1999 and 2024. We included observational studies conducted in Saudi Arabia reporting the risk factors, prevalence, and outcomes of preeclampsia.Overall, 21 studies were included in the analysis, of which 15 analyzed prevalence. The prevalence of preeclampsia in Saudi Arabia was 4.80%, with higher rates reported in cross-sectional studies (9.52%). Only 27% of women demonstrated preeclampsia awareness, and the key identified risk factors included serum lead, immunoglobulin A nephropathy, and calcium, magnesium, and zinc deficiencies. Adverse maternal outcomes included hemolysis, elevated liver enzymes, and low platelet syndrome and eclamptic seizures, whereas fetuses faced significant risks, including stillbirth, prematurity, and intrauterine growth restriction (IUGR).Preeclampsia poses a significant health burden in Saudi Arabia, which is compounded by limited public awareness and critical risk factors. These findings underscore the urgent need for improved preeclampsia screening and education in expectant mothers. Enhanced antenatal care and public health initiatives targeting preeclampsia awareness may improve maternal and fetal outcomes and reduce the long-term health burdens associated with this condition.
Prehospital Emergency Care · مجلد 30 (6) · 795-803
OBJECTIVES: Sepsis is a life-threatening condition that results in significant morbidity and mortality, particularly when progressing to septic shock. Early detection and treatment, especially before hospital arrival, are crucial for improving outcomes. This review aimed to identify, assess, and summarize studies on the effectiveness of early detection methods and prehospital interventions in enhancing survival rates for patients with sepsis. METHODS: This descriptive systematic review followed the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols guidelines. A comprehensive literature search was conducted across six electronic databases to identify relevant studies published up to November 2024. Studies were screened and independently reviewed by four reviewers, and bias was assessed using the Cochrane Risk of Bias tool for randomized controlled trials (RCTs) and the Methodological Index for Non-Randomized Studies tool for observational studies. RESULTS: This review included 23 studies comprising 16,246 patients. Most of the studies were retrospective (57%), with RCTs (22%) and prospective observational studies (13%). Prehospital interventions-including antibiotic therapy (ABT), intravenous fluids, and norepinephrine-were associated with improved outcomes. Antibiotic therapy significantly reduced 30-day mortality. Norepinephrine improved survival, and early intravenous fluid administration lowered hospital mortality. The National Early Warning Score was superior to the quick Sequential Organ Failure Score in screening for sepsis (area under the receiver operating characteristic curve, 0.74 vs. 0.68). Emergency medical services (EMS) tools enhanced adherence to the 3-h sepsis bundle (80% vs. 44.2%). CONCLUSIONS: Early antibiotic administration, fluid resuscitation, and hemodynamic stabilization reduce mortality rates and improve clinical outcomes. Validated sepsis screening tools exhibit predictive utility and may support EMS protocols for earlier recognition, though evidence linking their use to improved outcomes remains limited.
Saudi Journal of Anaesthesia · مجلد 19 (4) · 607-613
To examine the role of Transcutaneous Electrical Nerve Stimulation (TENS) in pain management post-laparoscopic cholecystectomy (LC). An in-depth search was conducted on Google Scholar, PubMed, and Ovid MEDLINE from their inception until November 2024. We included randomized controlled trials and prospective studies that compared TENS for postoperative pain relief as determined by the Visual Analog Scale (VAS). The quality assessment using the GRADE and Cochrane risk of bias methods. Six trials, comprising a total of 423 patients, were included in the study. The meta-analysis of the VAS at different times yielded no significant reduction in pain observed postoperatively at 4 hours (MD: −0.70, CI: −1.97 to 0.57, P = 0.28); at 8 hours (MD: −0.75, CI: −2.15 to 0.65, P = 0.29); and at discharge (MD: −0.88, CI: −2.02 to 0.26, P = 0.13). While the included studies showed minimal risk of bias, the certainty of evidence by the GRADE assessment was deemed low. While some studies suggest a potential benefit of TENS in reducing postoperative pain, the current evidence remains inconclusive due to the variability in study design, TENS parameters, and outcome reporting. Additional high-quality RCTs are required.
Immunity Inflammation and Disease · مجلد 13 (9) · e70253-e70253
OBJECTIVES: The current systematic review and meta-analysis aims to assess the safety and immunogenicity of the anticaries vaccines currently available. MATERIALS AND METHODS: Electronic searches of PubMed, Scopus, Web of Science and Science Direct were performed. Studies assessing the safety and effectiveness of the anticaries vaccination, including the dose, plasmids, serum IgG and IgA levels after immunization, were included. Studies in which animals were used for anticaries vaccine were also included. Combining more than one trial was done to estimate the pooled intervention effect using the meta-analysis when studies examined the same intervention and outcomes with comparable methods in similar populations. The continuous data was pooled using the inverse variance method, and dichotomous data using the Mantel-Haenszel method. RESULTS: Out of 4701 records, only 17 publications met the eligibility criteria. Although all studies were assessed as having an overall low risk of bias, certain domains (D3, D5, and D7) exhibited a high risk across most studies. The pooled RR, derived using a random-effects model, was 0.53 (95% CI: 0.46-0.62), indicating a statistically significant 47% reduction in risk across studies. CONCLUSIONS: There is excellent potential for dental caries vaccines to transform oral health in the future. Various vaccines, such as Killed Formalin-treated Donor strain 2 - recombinant Protein Antigen c and anti-CAT-SYIIgY antibodies, have demonstrated prophylactic effects against Streptococcus mutans colonization on teeth. These interventions exhibit a sustained reduction in S. mutans colonization, which may contribute to the prevention of dental caries. A vaccination of this kind would significantly lower tooth decay prevalence and the financial and health costs that go along with it.
Objective This study evaluated the impact of adenotonsillectomy on asthma symptoms in children by combining observational evidence with pooled analysis.Data sources We searched MEDLINE/PubMed, Cochrane Central Register of Controlled Trials, Web of Science, ProQuest, and Scopus from inception to March 17, 2025.Study selection Eligible studies assessed asthma outcomes in children undergoing adenotonsillectomy using retrospective or prospective cohort designs, case series, or database analyses. Eleven studies involving 74,204 participants were identified. Outcomes included asthma control scores (ACT/cACT), acute asthma exacerbations (AAEs), emergency department (ED) visits, oral corticosteroid use, hospitalization, inflammatory biomarkers, and atopic risk. Risk of bias was evaluated using ROBINS-I.Results Meta-analysis incorporated five studies with 52,479 participants. Adenotonsillectomy improved ACT/cACT scores by a mean of 2.5 points (95% CI:1.6–3.4; I2=0%), indicating better asthma control. A reduced risk of AAEs was observed (RD = 0.29; 95% CI:0.01–0.58), though with extreme heterogeneity (I2=100%). ED visits showed a small but significant reduction (MD=–0.01; 95% CI:0.00–0.02; I2=0%). Narrative synthesis found corticosteroid courses decreased by 23.7%, hospitalization rates fell by up to 35.8%, and patients reported improved quality of life and lower inflammatory biomarkers. However, most studies carried moderate to severe risk of bias due to confounding and selection issues.Conclusions Adenotonsillectomy may improve asthma control, reduce ED visits, and lessen medication use and hospitalization among children. Evidence regarding its effect on exacerbations remains inconsistent, and causality cannot be inferred due to reliance on observational data. Well-designed prospective controlled trials are needed to confirm effectiveness and clarify underlying mechanisms.
Background: Intracerebral hemorrhage management presents clinicians with a significant therapeutic challenge. Maintaining antiplatelet therapy potentially increases the risk of recurrent bleeding, while discontinuation heightens susceptibility to ischemic stroke, particularly during the critical first month after hemorrhage. In contemporary practice, physicians demonstrate considerable hesitancy regarding early antiplatelet reinitiation, complicated by the absence of clear evidence-based treatment guidelines. Aim: This meta-analysis assesses the safety of early antiplatelet resumption following ICH. Methods: We conducted a systematic review by searching Web of Science, Scopus, PubMed, and Cochrane Library from inception to April 2025. Articles were independently screened and data extracted by two reviewers who also assessed study quality. The inclusion criteria are enrollment of adults (≥18 years) with imaging-confirmed intracerebral hemorrhage surviving >24 h, comparing early vs. delayed or withheld antiplatelet therapy. Randomized trials underwent separate evaluation using Cochrane’s Risk of Bias. Statistical analysis was performed using R software (version 4.4.2), with categorical outcomes pooled as risk ratios (RRs) with 95% confidence intervals. Statistical significance was established at p < 0.05. The evidence is limited by the availability of few RCTs, variable antiplatelet regiments, male predominance, and other confounding factors. The review was registered in SFO. Results: Our meta-analysis included 10 studies (8 observational, 2 RCTs) with 5554 patients. Early antiplatelet therapy significantly reduced recurrent intracerebral hemorrhage by 46% (RR 0.54, 95% CI 0.37–0.78, p = 0.001). All-cause mortality showed a non-significant difference (RR 0.81, 95% CI 0.65–1.01, p = 0.06). No significant differences were found for ischemic stroke (RR 0.99, 95% CI 0.60–1.63, p = 0.96), major hemorrhagic events (RR 0.75, 95% CI 0.49–1.13, p = 0.17), or ischemic vascular outcomes (RR 0.71, 95% CI 0.49–1.02, p = 0.60). Conclusions: Our meta-analysis reveals that early antiplatelet therapy following intracerebral hemorrhage significantly reduces recurrent hemorrhagic events (46% reduction) without increasing major ischemic or hemorrhagic complications.
Self-monitoring of blood glucose (SMBG) is a widely used strategy in diabetes management, allowing patients to track their glucose levels and make informed decisions regarding diet, medication, and lifestyle adjustments. The effectiveness of SMBG remains debated. Structured SMBG, which involves systematic monitoring with clear guidance, has been suggested to provide greater benefits compared to unstructured SMBG. We aimed to evaluate the effectiveness of SMBG in improving glycemic control among diabetic patients. A systematic search was conducted in PubMed, the Cochrane Library, and Google Scholar. Studies were included if they examined SMBG interventions and reported glycated hemoglobin (HbA1c) as an outcome. Randomized controlled trials (RCTs) and observational studies were assessed for quality using the Cochrane Risk of Bias Tool and the Newcastle-Ottawa Scale. Meta-analysis was performed using Review Manager (RevMan, The Cochrane Collaboration, Copenhagen, Denmark) to calculate mean differences (MD) and 95% confidence intervals (CI). The comprehensive database search yielded 7,667 records, of which 22 articles were selected for review and analysis. The meta-analysis of 22 studies showed that SMBG significantly reduced HbA1c levels compared to no SMBG (MD = -0.32%, 95% CI: -0.44% to -0.20%). Structured SMBG resulted in a greater reduction (MD = -0.25%, 95% CI: -0.41% to -0.09%) compared to unstructured SMBG. In summary, we showed that SMBG is effective in lowering HbA1c, particularly when structured protocols are followed. Healthcare providers should promote structured SMBG, along with patient education, to enhance adherence and optimize glycemic control. Further long-term studies are necessary to evaluate long-term benefits.
self-monitoring of blood glucoseglycemic controldiabetes mellitusHbA1c
Abstract Purpose Angiotensin receptor-neprilysin inhibitors (ARNI) are well-established for chronic heart failure (HF) with reduced ejection fraction. However, their efficacy and safety when initiated in acute decompensation (ADHF) remain less well characterized. This meta-analysis evaluates the efficacy and safety of ARNI compared to angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) for ADHF. Methods A meta-analysis of randomized controlled trials (RCTs) retrieved from PubMed, Scopus, WOS, Embase, and CENTRAL till November 2024. Risk ratios (RR) were applied for dichotomous outcomes and standardized mean differences (SMD) for continuous outcomes, both with 95% confidence intervals (CI). Results Three RCTs with 1,741 patients were included. Use of ARNI after stabilization of ADHF resulted in a significant reduction of HF rehospitalization/all-cause mortality (RR: 0.71; 95% CI: 0.57 to 0.88; p < 0.01), HF rehospitalization (RR: 0.73; 95% CI: 0.57 to 0.93; p = 0.01), worsening renal function (RR: 0.80; 95% CI: 0.64 to 1.00; p = 0.048), and NT-proBNP at 4 weeks (SMD: -0.24; 95% CI: -0.34 to -0.14; p < 0.0001) or 8 weeks (SMD: -0.21; 95% CI: -0.31 to -0.10; p = 0.0001). However, ARNI was associated with a higher risk of symptomatic hypotension (RR: 1.33; 95% CI: 1.04 to 1.71; p = 0.024). Conclusion Pooled data demonstrate that the initiation of ARNI post-ADHF can be effective compared with ACEIs/ARBs for both cardiovascular and renal benefits at the expense of increased risk for symptomatic hypotension.
Journal of Pioneering Medical Science · مجلد 14 (Special Issue 1) · 464-472
Background: Androgenetic alopecia (AGA) is the most common disorder of hair loss in men and women. Minoxidil is one of the drugs that are widely used for the treatment of hair loss and commercially available as oral or topical preparations. This systematic review with meta-analysis was thus intended to compare the efficacy and safety profile of oral minoxidil and topical minoxidil in the treatment of AGA. Methods: A systematic literature search was conducted across seven major databases: PubMed, Scopus, Web of Science, Cochrane Library, Embase, CINAHL and PsycINFO. After close filtering, four studies were selected for meta-analysis where the efficacy and safety of oral and topical minoxidil for the treatment of AGA were studied. Results: Meta-analytic results did not express a statistically significant superiority of oral minoxidil over the topical minoxidil in promoting healthy hair growth, that is, the odds ratio 2.23 (95% CI: 0.84, 5.93) with a p-value 0.11 for a test of overall effect and Z = 1.60, with heterogeneity (Tau²=0.00); meaning homogeneity among the studies. The incidence of adverse events was also more in the oral minoxidil compared to the oral finasteride. However, it included hypertrichosis, tachycardia and scalp pruritus with OR, 3.33 (95% CI: 1.40, 7.90) and p-value of 0.006. Qualitatively, the studies unveiled that oral and topical minoxidil have efficacy in the treatment of AGA but to different degrees of efficacy and tolerability. Conclusion: The clinical benefits of oral and topical minoxidil were the same when used in the treatment of AGA, however, hair density improved better with topical minoxidil and adverse effects were minimum.
Nanotechnology-enhanced materials and smart implants are emerging technologies that have shown promise in addressing various challenges in general surgery, including infection management, oncologic staging, and complication monitoring. In this systematic review, we aimed to examine the safety and efficacy of these technologies compared with conventional methods in patients undergoing general surgical procedures. A comprehensive search was conducted in MEDLINE (via PubMed), Embase, Scopus, Web of Science, the Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, WHO ICTRP, IEEE Xplore/Inspec, and Google Scholar according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, using standardized keywords related to nanotechnology, surgery, and clinical outcomes. The included studies were categorized according to intervention class and procedural type. Risk of bias was assessed using RoB 2 for randomized trials and ROBINS-I for nonrandomized studies, while outcome certainty was evaluated using GRADE. Nine eligible studies were included, comprising a total of 2,250 participants (infection prevention: 974; mapping/staging: 1,244; sensing: 32 drain-fluid samples). Due to heterogeneity among the studies, a meta-analysis could not be performed, and the results were therefore synthesized narratively. Silver-based topical creams and dressings demonstrated early bacterial clearance and improved wound healing. Carbon nanoparticle (CNP) suspensions enhanced lymph node detection sensitivity and preserved parathyroid hormone in thyroid cancer and nearly doubled sensitivity to micrometastatic lymph nodes in gastric cancer. Silver-ion-impregnated tracers in breast cancer showed comparable sensitivity for sentinel lymph node detection. Silver-ion-impregnated meshes showed no significant difference compared with conventional meshes. Overall, adverse effects were minimal or absent. In conclusion, nanotechnology-enhanced materials and smart implants show substantial potential to improve infection prevention, oncologic staging, and perioperative monitoring in general surgery, with minimal adverse effects. Silver-based topical antimicrobials, CNP suspensions, superparamagnetic iron oxide tracers, and innovative biosensor technologies were either comparable or superior to conventional alternatives. However, a clear knowledge gap regarding long-term outcomes and the heterogeneity of comparators highlights the need for larger, rigorously designed studies to guide clinical adoption.
smart implantsgeneral surgerysurgical site infection preventionlymphatic mapping
Background and Objectives Hand and wrist fractures are among the most frequently encountered injuries in emergency departments and are often misdiagnosed, particularly when interpreted by non-specialist clinicians. These diagnostic errors can lead to treatment delays and long-term complications. Artificial intelligence (AI), particularly deep learning algorithms, is emerging as a promising adjunct to improve diagnostic accuracy in radiographic fracture detection. This study aims to evaluate the effectiveness of Artificial Intelligence (AI) in detecting hand and wrist fractures compared to manual radiographic interpretation by clinicians. Materials and Methods A systematic review and meta-analysis were conducted to assess the diagnostic performance of AI models in detecting hand and wrist fractures compared to conventional radiographic interpretation by clinicians. A comprehensive search of PubMed, Google Scholar, Science Direct, and Wiley Online Library was performed. Eligible studies included those utilizing AI for fracture detection with sensitivity and specificity data. Pooled estimates were calculated using fixed- and random-effects models. Heterogeneity was assessed via I 2 statistics, and publication bias was examined using funnel plots and Egger’s test. Results Eighteen studies met inclusion criteria. The pooled sensitivity and specificity under the random-effects model were 0.910 and 0.912, respectively, indicating high diagnostic accuracy of AI models. However, substantial heterogeneity (I 2 = 99.09% for sensitivity; 96.43% for specificity) and publication bias were observed, likely due to variations in AI algorithms, sample sizes, and study designs. Conclusions Most AI models demonstrated good diagnostic accuracy, with high sensitivity and specificity scores (≥90%). However, some models fell short in sensitivity and specificity (≤90%), indicating performance variations across different AI models or algorithms. From a clinical perspective, AI models with lower sensitivity scores may fail to detect hand and wrist fractures, potentially delaying treatment, while those with lower specificity scores could lead to unnecessary interventions—treating hands and wrists that are not fractured.
hand fractureswrist fracturesartificial intelligencedeep learning
Background: Medication turnaround time (TAT) is a critical metric for evaluating the efficiency and safety of hospital pharmacy operations. Optimizing TAT is essential to ensure patient safety, reduce medication errors, enhance workflow efficiency, enhance resource utilization and enhance both the continuity of care and patient satisfaction. Aim: To discuss the important of TAT, factors influencing medication TAT and provide evidence-based recommendations to optimize medication delivery thereby improve patient care. Methods: A comprehensive search of PubMed, Google Scholar, and ScienceDirect was conducted up to June 15, 2025. Eligible studies included if they were conducted in inpatient settings and reported medication TAT as outcome. Outpatient studies and those without relevant data were excluded. Data on study characteristics, interventions, and outcomes were extracted and summarized narratively; no meta-analysis was performed due to the heterogeneity of the studies. Results: Analysis identified several determinants of prolonged TAT included inefficient health IT systems, inadequate communication, staffing limitations, and inconsistent workflows. Effective interventions encompassed automation, workflow redesign, staff role optimization, and process standardization. These strategies consistently reduced TAT, with reported improvements of 10% to over 50%. Conclusion: TAT is a fundamental indicator to measure hospital pharmacy performance and improve patient outcomes. Addressing the barriers through evidence-based strategies can significantly streamline the medication use process. Optimizing medication TAT requires a multifaceted approach that include integrates technology, standardized workflows, and improve human factors. Evidence suggests these approaches not only enhance operational efficiency but also reduce errors, strengthen regulatory compliance, and ultimately improve patient safety as well as satisfaction.